Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.072 | 0.7 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |